Synergy of HDACi, PARPi and Chemotherapeutics Against Blood Cancer
Researchers investigated the efficacy of HDAC inhibitors in combination with PARP inhibitors and chemotherapeutic drugs... read more
October 19, 2022
Tagged: drug resistance
Epigenetics and Immunotherapy Combined Fights Rare Lymphoma
In a new Oncotarget study, researchers assessed an epigenetic and immunotherapy treatment regimen among patients... read more
August 24, 2022
Trending With Impact: Genes Identified in Endocrine Therapy Resistance
Researchers studied the dynamic behavior of gene expression during the development of endocrine therapy resistance... read more
April 14, 2022
New Study: ATR Inhibition Reverses Chemo-Resistance in Subset of Cells
Ataxia telangiectasia and Rad3 (ATR) inhibition was targeted in an attempt to overcome temozolomide (TMZ)... read more
October 13, 2021
Trending With Impact: Low-Dose Chemo Inhibits Resistant Breast Cancer
In this trending in vitro study, researchers assessed the efficacy of low-dose 6-mercaptopurine and 5-azacitidine... read more
June 17, 2021
Trending With Impact: RNA Modification Regulatory Proteins in Melanoma
Researchers analyzed various publicly available datasets and identified two RNA modification regulatory proteins that are... read more
May 20, 2021
Symmetrically Dividing Prostate Cancer Cells Drive Exponential Growth
Researchers in this study use scaling analysis to show that, in patients with prostate cancer... read more
January 5, 2021